We demonstrated that prolonged exposure to cisplatin desensitized NSCLC cells to cisplatin, leading to the development of cisplatin-resistant NSCLC cells with CSC-like phenotypes that are characterized by enhanced SREBP-1-mediated lipogenesis. Here, SREBF1 is linked to non-small cell lung carcinoma.